74 related articles for article (PubMed ID: 11131300)
1. Histamine up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils.
Dasí FJ; Ortiz JL; Cortijo J; Morcillo EJ
Inflamm Res; 2000 Nov; 49(11):600-9. PubMed ID: 11131300
[TBL] [Abstract][Full Text] [Related]
2. beta-Adrenoceptor stimulation up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils.
Ortiz JL; Dasí FJ; Cortijo J; Morcillo EJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):410-7. PubMed ID: 10763856
[TBL] [Abstract][Full Text] [Related]
3. Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists.
Torphy TJ; Zhou HL; Foley JJ; Sarau HM; Manning CD; Barnette MS
J Biol Chem; 1995 Oct; 270(40):23598-604. PubMed ID: 7559525
[TBL] [Abstract][Full Text] [Related]
4. Histamine up-regulates phosphodiesterase IV activity in U-937 cells through H2 receptor stimulation and cAMP increase.
Delgado M; Fuentes JA; Fernandez-Alfonso MS
Med Sci Monit; 2003 Jun; 9(6):BR212-9. PubMed ID: 12824943
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
Torphy TJ; Zhou HL; Cieslinski LB
J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
[TBL] [Abstract][Full Text] [Related]
6. Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B.
Manning CD; McLaughlin MM; Livi GP; Cieslinski LB; Torphy TJ; Barnette MS
J Pharmacol Exp Ther; 1996 Feb; 276(2):810-8. PubMed ID: 8632354
[TBL] [Abstract][Full Text] [Related]
7. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
[TBL] [Abstract][Full Text] [Related]
8. mRNA expression and antilipolytic role of phosphodiesterase 4 in rat adipocytes in vitro.
Wang H; Edens NK
J Lipid Res; 2007 May; 48(5):1099-107. PubMed ID: 17267946
[TBL] [Abstract][Full Text] [Related]
9. Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture.
Méhats C; Tanguy G; Dallot E; Robert B; Rebourcet R; Ferré F; Leroy MJ
Endocrinology; 1999 Jul; 140(7):3228-37. PubMed ID: 10385419
[TBL] [Abstract][Full Text] [Related]
10. Functional desensitization due to stimulation of cyclic AMP-phosphodiesterase in human mononuclear leukocytes.
Chan SC; Grewe SR; Stevens SR; Hanifin JM
J Cyclic Nucleotide Res; 1982; 8(4):211-24. PubMed ID: 6300207
[TBL] [Abstract][Full Text] [Related]
11. Is up-regulation of phosphodiesterase 4 activity by PGE2 involved in the desensitization of beta-mimetics in late pregnancy human myometrium?
Méhats C; Tanguy G; Dallot E; Cabrol D; Ferré F; Leroy MJ
J Clin Endocrinol Metab; 2001 Nov; 86(11):5358-65. PubMed ID: 11701706
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
Jones NA; Leport M; Holand T; Vos T; Morgan M; Fink M; Pruniaux MP; Berthelier C; O'Connor BJ; Bertrand C; Page CP
Pulm Pharmacol Ther; 2007; 20(1):60-8. PubMed ID: 16427796
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of phosphodiesterase activity, airway inflammation and hyperresponsiveness by PDE4 inhibitor and glucocorticoid in a murine model of allergic asthma.
Sun JG; Deng YM; Wu X; Tang HF; Deng JF; Chen JQ; Yang SY; Xie QM
Life Sci; 2006 Oct; 79(22):2077-85. PubMed ID: 16875702
[TBL] [Abstract][Full Text] [Related]
14. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
Verghese MW; McConnell RT; Lenhard JM; Hamacher L; Jin SL
Mol Pharmacol; 1995 Jun; 47(6):1164-71. PubMed ID: 7603456
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta induces phosphodiesterase 4B2 expression in human myometrial cells through a prostaglandin E2- and cyclic adenosine 3',5'-monophosphate-dependent pathway.
Oger S; Méhats C; Dallot E; Ferré F; Leroy MJ
J Clin Endocrinol Metab; 2002 Dec; 87(12):5524-31. PubMed ID: 12466348
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
[TBL] [Abstract][Full Text] [Related]
17. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
Zhu B; Kelly J; Vemavarapu L; Thompson WJ; Strada SJ
Biochem Pharmacol; 2004 Aug; 68(3):479-91. PubMed ID: 15242814
[TBL] [Abstract][Full Text] [Related]
18. A role for cyclic nucleotide phosphodiesterase 4 in regulation of the growth of human malignant melanoma cells.
Narita M; Murata T; Shimizu K; Nakagawa T; Sugiyama T; Inui M; Hiramoto K; Tagawa T
Oncol Rep; 2007 May; 17(5):1133-9. PubMed ID: 17390056
[TBL] [Abstract][Full Text] [Related]
19. The effects of increased cAMP content on inflammation, oxidative stress and PDE4 transcripts during Brucella melitensis infection.
Erdogan S; Aslantas O; Celik S; Atik E
Res Vet Sci; 2008 Feb; 84(1):18-25. PubMed ID: 17397885
[TBL] [Abstract][Full Text] [Related]
20. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
Zhou L; Thompson WJ; Potter DE
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]